Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care

Cardiovascular disease remains the leading cause of death in the world and continues to serve as the major contributor to healthcare costs. Likewise, there is an ever-increasing need and demand for novel and more efficient diagnostic tools for the early detection of cardiovascular disease, especiall...

Full description

Saved in:

Bibliographic Details
Published in:	Methodist DeBakey cardiovascular journal Vol. 8; no. 1; pp. 6 - 12
Main Authors:	Christodoulides, Nicolaos, Pierre, Floriano N, Sanchez, Ximena, Li, Luanyi, Hocquard, Kyle, Patton, Aaron, Muldoon, Rachna, Miller, Craig S, Ebersole, Jeffrey L, Redding, Spencer, Yeh, Chih-Ko, Furmaga, Wieslaw B, Wampler, David A, Bozkurt, Biykem, Ballantyne, Christie M, McDevitt, John T
Format:	Journal Article
Language:	English
Published:	United States 01-01-2012
Subjects:	Animals Biomarkers - analysis Cardiology - instrumentation Cardiology - methods Cardiovascular Diseases - diagnosis Cardiovascular Diseases - metabolism Early Diagnosis Equipment Design Humans Lab-On-A-Chip Devices Nanomedicine - instrumentation Point-of-Care Systems Predictive Value of Tests Prognosis Reproducibility of Results point of care testing cardiovascular disease bio-nanochips P-BNC cardiac biomarkers in vitro diagnostics lab-on-a-chip technologies programmable bio-nanochips
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!